| |
|
|
 |
|
 |
|
|
|
Reliance Life Sciences is a new millennium
initiative of the Reliance
Group of companies.
The vision of Reliance Life Sciences is
to attain global leadership through innovative
and cost-effective solutions for a better
life.
Mukesh
Ambani led Reliance Group is the largest private
sector enterprise in India, participating
in businesses in the energy and materials
value chain, with group revenues of USD
29 billion. The flagship company, Reliance
Industries Limited, is a Fortune
Global 500 company.
Reliance Life Sciences is a research-driven,
biotechnology-led, life sciences organization.
Reliance Life Sciences participates in
medical, plant and industrial biotechnology
opportunities. Specifically, these relate
to Biopharmaceuticals, Pharmaceuticals,
Clinical Research Services, Regenerative
Medicine, Molecular Medicine, Novel Therapeutics,
Biofuels, Plant Biotechnology and Industrial
Biotechnology.
Reliance Life Sciences is developing business
opportunities in the domains of medical,
plant and industrial biotechnology.
From a domain perspective, these opportunities
cover:
| a. |
Biopharmaceuticals (Plasma Proteins,
Biosimilars (Recombinant Proteins,
Monoclonal Antibodies) and Novel Proteins) |
| b. |
Pharmaceuticals (Oncology, Steroid,
Hormone and Peptide - Active Pharmaceutical
Ingredients and Formulations ) |
| c. |
Clinical Research Services (Pre-clinical
animal studies, Bioavailability and
Bioequivalence studies, Phase 1 studies,
Phase 2 to 4 studies, QTc studies,
Mass balance/Micro dosing studies,
Clinical Data Management, Biostatistics,
Clinical Trial Supplies Management,
Medical Writing, Pharmacovigliance,
Regulatory Services and Quality Assurance
) |
| d. |
Regenerative Medicine (Stem Cell
therapies, Tissue Engineered products,
Stem Cell enriched Repository Services,
Assisted Reproduction and Fetal Medicine)
|
| e. |
Molecular Medicine (DNA/RNA-based
diagnostics, Molecular Genetics, Predictive
Diagnostics, Histopathology, Cytopathology,
Flow Cytometry based diagnosis, Pharmacogenomics) |
| f. |
Novel Therapeutics (siRNA Therapies) |
| g. |
Biofuels (Biodiesel, Bioethanol,
Biobutanol) |
| h. |
Plant Tissue Culture |
| i. |
Plant Metabolic Engineering and |
| j. |
Industrial Biotechnology (Biopolymers,
Biochemicals) |
| k. |
Enzymology |
From an integration perspective, these
opportunities encompass Repositories,
Research, Process Development, Pre-clinical
Studies, Human Clinical Trials, Commercial-scale
Manufacture and Marketing, all of which
are carried out in-house.
Reliance GeneMedix plc, a UK-based subsidiary
of Reliance Life Sciences with a manufacturing
facility in Ireland, is developing biosimilars
for the European market.
Reliance Institute of Life Sciences is
a not-for-profit organisation, sponsored
by the Dhirubhai Ambani Foundation, focusing
on competency development in Biotechnology,
not only for Reliance Life Sciences but
also for the industry. The Institute offers
a wide range of competency development
programs and diploma programs in Biotherapeutics
and Clinical Research.
Reliance Life Sciences initiative is one
of the most diverse and integrated biotechnology
initiatives being developed anywhere in
the world.
Consistent with the diversity and depth
of its initiatives, Reliance Life Sciences
has a professional team comprising substantially
of Ph. Ds, M.Ds, Engineers and Post Graduates
in Science. The average age of the Reliance
Life Sciences team is 32 years. 30% of
the employees are women.
The main campus of the Reliance Life
Sciences is located at the Dhirubhai Ambani
Life Sciences Center (DALC) on a 20-acre
site at Navi Mumbai. Clinical Research
Services are provided out of DALC and
a facility in Bangalore. Biofuels agronomy
research is conducted at farms in Kakinada,
Raviguntapalli, Nagothane and Gandhar.
|
|
|
|
|
|
|
|
|
|
|
